Vitamin D is useless against severe COVID-19, research claims
A high dose of vitamin D does not improve the condition of patients with moderate to severe COVID-19, Journal of the American Medical Association reported.
The double-blind, randomized, placebo-controlled study involved 240 patients with coronavirus, who were divided into two groups. One group received vitamin D3 in a single dose of 200,000 international units (IU), found in peanut butter. The control group was given a peanut butter placebo. All patients received a standard course of treatment, including antibiotics and anti-inflammatory drugs.
The study authors wanted to find out if vitamin D could reduce the time that coronavirus patients stay in hospital. The researchers also assessed its effect on the risk of admission to the intensive care unit, intubation, or death.
The study found that there is no rationale for using a high dose of vitamin D in patients with severe COVID-19.
However, this does not mean that there are no positive effects from the constant use of this vitamin.
According to experts, the elderly and patients with chronic diseases, such as osteoporosis, should have a vitamin D level of more than 30 nanograms per milliliter of blood (ng / ml). For healthy adults, an acceptable amount is 20 ng / ml.




















Unibank Launches Biometric Identification in UNIMobile App
Unisport reaches the finals of the Futsal Armenian Cup and Premier League
IDBank was the strategic partner of the “Women in Leadership Forum & Awards 2026”
Unibank Launches Fee-Free Online Payroll Card Issuance
Ucom Supported the First-ever Western Asia Regional FPV Drone Race in Armenia
Unisport – Armenian Futsal Cup holder
Team Holding Announces the Launch of the Third and Final Placement Phase of USD Bonds. Underwriter -...
Love Is… card from Unibank can win a trip to Paris
Learn by Playing. A Series of Financial Literacy Games with Idram, IDBank and “Novosti-Armenia”
Ucom and the Microsoft Innovation Center Collaborate on Cybersecurity Education